We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. FDA Commissioner: Transparency Needed Among International Regulators
U.S. FDA Commissioner: Transparency Needed Among International Regulators
July 10, 2012
PHILADELPHIA — The U.S. Food and Drug Administration (FDA) and international regulators must establish a much more collaborative framework in order to ensure the safety of the world’s drug supply chains, FDA Commissioner Margaret Hamburg says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor